A comparison between Intrathecal 0.75% hyperbaric Ropivacaine with or without Fentanyl in lower abdominal surgeries

A Comparative study of Intrathecal 0.75% Ropivacaine(H) with or without Fentanyl in lower abdominal surgeries - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058756

Enrollment

Registered

2023-10-17

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: 0.75% Ropivacaine(H) with fentanyl: Single Centered, Randomized clinical trial , Single Blind , 44 patients will be randomly allocated to receive Intrathecal of 0.75 % ropivacaine (3.0

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA physical status 1 and 2 2. Age 19-60 years 3. Both gender 4. Lower abdominal surgeries

Exclusion criteria

Exclusion criteria: 1. patient not giving consent 2. known hypersensitivity to any of the drugs 3. ASAgrade >2 4. Any contraindications to spinal Anesthesia

Design outcomes

Primary

Measure	Time frame
To compare the time to reach peak sensory block level in both the groupsTimepoint: 24 h postoperative	—

Secondary

Measure	Time frame
To compare Time to reach peak motor block - Modified Bromage scale grade 3, Duration of analgesia, Incidence of any side effects Timepoint: 24 h postoperative	—

Countries

India

Contacts

Public ContactDr AK SINHA

GMC Haldwani Nainital

drajayksinha@yahoo.co.in9302694817

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026